Quick Answer
Sanara MedTech Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $103.12 million for the year ending 2025.
- Sanara MedTech Inc. showed an increase of +19.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Sanara MedTech Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $5.01 million | Q2 2021: $6.28 million | Q3 2021: $5.82 million | Q1 2022: $7.81 million | Q2 2022: $9.67 million | Q3 2022: $13.04 million | Q1 2023: $15.52 million | Q2 2023: $15.75 million | Q3 2023: $16.02 million | Q1 2024: $18.54 million | Q2 2024: $20.16 million | Q3 2024: $21.67 million | Q1 2025: $23.43 million | Q2 2025: $25.83 million | Q3 2025: $26.33 million.
- Over the full 6 years of available data (2020 to 2025), Sanara MedTech Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 561.6%.
- Historical annual values: Fiscal year 2025: $103.12 million | Fiscal year 2024: $86.67 million | Fiscal year 2023: $64.99 million | Fiscal year 2022: $45.84 million | Fiscal year 2021: $24.14 million | Fiscal year 2020: $15.59 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: